EMEA-001174-PIP03-18

Key facts

Active substance
Turoctocog alfa pegol
Therapeutic area
Haematology-Hemostaseology
Decision number
P/0046/2019
PIP number
EMEA-001174-PIP03-18
Pharmaceutical form(s)
Powder and solvent for solution for injection
Condition(s) / indication(s)
Treatment of congenital haemophilia A
Route(s) of administration
Subcutaneous use
Contact for public enquiries
Novo Nordisk A/S
Denmark
Tel. +45 44448888
E-mail: paediatrics@novonordisk.com
Decision type
W: decision granting a waiver in all age groups for all conditions/indications

Decision

How useful was this page?

Add your rating